A study on the relationship between succinate dehydrogenase and mitoKATPC in the mechanism of ischemic postconditioning protecting against MIRI under CPB in adult rats

Author:

Du Kang1,Wang Yan1,Tang Kun2,Chen Wei1,Zhou Wenjing1,Zhang Yu1,Wang Haiying1

Affiliation:

1. Affiliated Hospital of Zunyi Medical University

2. The First Affiliated Hospital of Army Military Medical University

Abstract

Abstract Objective: To explore the relationship between succinate dehydrogenase and mitoKATPC in the mechanism of ischemic postconditioning (IPO) attenuating myocardial ischemia-reperfusion injury (MIRI) under CPB in adult rats. Methods: 160 adult male SD rats, SPF grade, weighing 300-350g. Established adult rat CPB ischemia-reperfusion and IPO models. Randomly divided into 8 groups with 20 animals in each group: normal group (Nor), SDH competitive inhibitor Dimethyl malonate (dm) control group (dm+ Nor), ischemia-reperfusion group (I// R), dm+ ischemia-reperfusion group (dm+ I/R), ischemia postconditioning group (IPO), dm+ ischemic postconditioning group (dm+ IPO), mitoKATPC specific inhibitor 5-hydroxydecanoic acid (5-HD) + ischemic postconditioning group (5-HD+IPO), dm+5-HD+ischemic postconditioning group (dm+5-HD+IPO). The blood was collected at the end of reperfusion and the rat hearts were harvested for the following tests: 1. Measure the myocardial infarct size (IS); 2. Observing the ultrastructure of the myocardium and calculating the mitochondrial Flameng score of the myocardial cells; 3. Creatine kinase-MB (CK-MB) and cardiac troponin I (cTnI) concentrations; 4. Reactive oxygen species (ROS) generation under confocal microscopy; 5. Myocardial determination SDH activity, content of succinic acid (SA) and fumaric acid (FA); 6. Determination of mRNA and protein expression of succinate dehydrogenase flavoprotein (SDHA) in myocardial tissue. Results: Compared with the Nor group, IS, mitochondrial Flameng score, CK-MB, cTnI, ROS content, SDH activity, SA content, SDHA mRNA expression and SDHA protein expression were significantly increased in the I/R group (P<0.05). Compared with the dm+ Nor group, there was no statistical difference (P>0.05); compared with the I/R group, both were decreased in the dm+ I/R group and the IPO group (P<0.05); compared with the IPO group, the dm+ IPO group decreased, and the 5-HD+IPO group increased (P<0.05); there was no significant difference between the 5-HD+IPO group and the dm+5-HD+IPO group (P>0.05) . The FA content is the opposite of the above results. Conclusion: The activity of SDH in myocardial ischemia is significantly increased, which leads to a significant increase in the expression of SDHA, which is involved in the mechanism of myocardial ischemia-reperfusion injury and inhibits the activity of SDH, which can effectively reduce MIRI. Ischemic postconditioning can open mitoKATPC and inhibit the activity of SDH to protect MIRI. The inhibitory effect of ischemic postconditioning on SDH activity is achieved by opening mitoKATPC.

Publisher

Research Square Platform LLC

Reference38 articles.

1. Mortality due to acute myocardial infarction in China from 1987 to 2014: Secular trends and age-period-cohort effects;Chang J;Int J Cardiol,2017

2. Proteomic footprint of myocardial ischemia/reperfusion injury: Longitudinal study of the at-risk and remote regions in the pig model;Binek A;Sci Rep,2017

3. Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction;Curran J;J Cardiovasc Transl Res,2019

4. Targeted mitochondrial drugs for treatment of myocardial ischaemia-reperfusion injury;Peng JF;J Drug Target,2022

5. Mechanism of the hypoxia inducible factor 1/hypoxic response element pathway in rat myocardial ischemia/diazoxide post–conditioning;Li J;Mol Med Rep,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3